Public Sector Pension Investment Board Has $7.58 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Public Sector Pension Investment Board cut its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 105,129 shares of the company’s stock after selling 4,700 shares during the period. Public Sector Pension Investment Board’s holdings in Prestige Consumer Healthcare were worth $7,580,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PBH. Opal Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare in the second quarter valued at approximately $26,000. Quest Partners LLC raised its holdings in shares of Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after purchasing an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Gladius Capital Management LP acquired a new stake in shares of Prestige Consumer Healthcare in the second quarter valued at approximately $35,000. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in shares of Prestige Consumer Healthcare by 562.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after purchasing an additional 433 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Price Performance

NYSE:PBH opened at $84.77 on Friday. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $86.36. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The firm has a fifty day simple moving average of $75.41 and a 200 day simple moving average of $71.16. The stock has a market capitalization of $4.19 billion, a PE ratio of 20.63, a P/E/G ratio of 2.37 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. During the same period in the previous year, the business posted $1.07 earnings per share. The company’s revenue for the quarter was down .9% compared to the same quarter last year. On average, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Jefferies Financial Group reissued a “hold” rating and issued a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reissued a “buy” rating and issued a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $83.67.

Insider Transactions at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 9,885 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total value of $810,273.45. Following the completion of the transaction, the senior vice president now owns 18,835 shares of the company’s stock, valued at $1,543,904.95. The trade was a 34.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Ronald M. Lombardi sold 10,875 shares of the business’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the transaction, the chief executive officer now directly owns 320,952 shares of the company’s stock, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 38,810 shares of company stock valued at $3,187,300. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.